COMMUNIQUÉS West-GlobeNewswire

TLC Announces Pricing of Initial Public Offering of American Depositary Shares (ADSs) on Nasdaq
21/11/2018
TAIPEI, Taiwan and SOUTH SAN FRANCISCO, Calif., Nov. 21, 2018 (GLOBE NEWSWIRE) -- Taiwan Liposome Company, Ltd. (4152.TWO) (TLC), a clinical-stage specialty pharmaceutical company dedicated to the development and [...]
The Phase III study protocol is modified after IBT’s meeting with the FDA
21/11/2018
The Phase III study protocol is modified after IBT’s meeting with the FDA Yesterday afternoon (EST) Infant Bacterial Therapeutics had a meeting with the US Food and Drug Administration (FDA) in Washington DC to discuss [...]
LIDDS adds two major university clinics in Lithuania to speed up enrollment in ongoing Phase IIb study
21/11/2018
The National Cancer Institute in Vilnius and the University Clinic of Kaunas are now ready to start inclusion of patients in Part II of the LPC-004 study. Lithuanian authorities have recently approved the study protocol [...]
UPDATE - BriaCell to Present Updated Clinical Data Including Early Safety Data in KEYTRUDA® Combination Study and Positive Phase IIa Monotherapy Efficacy Data at 2018 San Antonio Breast Cancer Symposium
21/11/2018
Note: This Press Release contains amendments to the press release previously issued on Nov. 19, 2018 Positive proof of concept data with Bria-IMT™ Monotherapy will highlight potent anti-tumor activity and an excellent [...]
ReWalk Robotics Announces Closing of $12.1 Million Public Offering
21/11/2018
Underwriters Exercise In Full Option to Purchase Additional Securities YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., Nov. 20, 2018 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ ReWalk ” or the “ Company ”) [...]
Tyme Technologies, Inc. to Present at the Evercore ISI, HealthconX Conference on November 27th
20/11/2018
NEW YORK, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME), a clinical stage biotechnology company developing cancer therapeutics to address multiple tumor types, today announced that it will be [...]
Amphastar Pharmaceuticals to Present at the 30th Annual Piper Jaffray Healthcare Conference 2018
20/11/2018
RANCHO CUCAMONGA, Calif., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO will be presenting at the 30 th Annual Piper Jaffray Healthcare Conference [...]
Novelion Therapeutics Announces Leadership Change
20/11/2018
Novelion General Counsel Benjamin Harshbarger Appointed as Interim Chief Executive Officer (CEO) VANCOUVER, British Columbia, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), today announced [...]
electroCore, Inc. to Present at the Evercore ISI HealthCONx Conference
20/11/2018
BASKING RIDGE, N.J., Nov. 20, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the company will be participating in the [...]
Nabriva Therapeutics to Present at the 30th Annual Piper Jaffray Healthcare Conference
20/11/2018
DUBLIN, Ireland and KING OF PRUSSIA, Pa., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ:NBRV), a clinical stage biopharmaceutical company engaged in the research and development of novel anti- [...]
Integra® XT Revision Total Ankle Replacement System Offers Innovative Solution to Ankle Arthroplasty Revision Surgery
20/11/2018
PLAINSBORO, N.J., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced one of the first surgeries with the Integra® XT [...]
Xtraction Services -- Revolutionary Technology, Service & Business Model -- CFN Media
20/11/2018
Seattle, WA, Nov. 20, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication [...]
Plus Products Top Edibles Brand in World's Largest Cannabis Market -- CFN Media
20/11/2018
SEATTLE, Nov. 20, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering [...]
Auxly Congratulates Partner ICC International Cannabis Corp on Acquisition of Cannabis Genetics Company Green Gene Research Inc
20/11/2018
VANCOUVER, British Columbia, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") is pleased to announce that its strategic international partner, ICC International [...]
Stryker to participate in Evercore ISI HealthCONx Conference
20/11/2018
Kalamazoo, Michigan, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the Evercore ISI HealthCONx Conference on Wednesday, November 28, 2018 at the Boston Harbor Hotel in Boston, Massachusetts. [...]
Capital Increase in Genmab as a Result of Employee Warrant Exercise
20/11/2018
Company Announcement Copenhagen, Denmark; November 20, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 7,588 shares as a consequence of the exercise of employee warrants. The increase is [...]
Santhera Calls Extraordinary General Meeting and Proposes Ordinary Share Capital Increase to Raise Approximately CHF 50 Million
20/11/2018
Pratteln, Switzerland, November 20, 2018 - Earlier today, Santhera Pharmaceuticals (SIX: SANN) announced that it has entered into an agreement to acquire the option for the exclusive sub-license to the first-in-class [...]
Santhera Enters into Agreement to Acquire Option from Idorsia for Exclusive Sub-License of First-in-class Dissociative Steroid Vamorolon
20/11/2018
Vamorolone in clinical development for Duchenne muscular dystrophy (DMD) by ReveraGen BioPharma Inc. - pivotal VISION-DMD Phase IIb study ongoing Vamorolone has the potential to become standard of care in young patients [...]
Santhera enters into agreement to acquire option from Idorsia for exclusive sub-license of first-in-class dissociative steroid vamorolone
20/11/2018
Vamorolone in clinical development for Duchenne muscular dystrophy (DMD) by ReveraGen BioPharma Inc. - pivotal VISION-DMD Phase 2b study ongoing Vamorolone has the potential to become standard of care in young patients [...]

Pages